Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ventripoint Diagnstcs Ltd (OP:VPTDF)

0.0611 -0.0006 (-0.97%)
Delayed Quote Updated: 11:58 AM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Ventripoint Diagnstcs Ltd

News headline image
Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging
Commercial initiative aims to make VMS+ easier for hospitals to evaluate and adopt 
From Ventripoint Diagnostics Ltd
Via GlobeNewswire
News headline image
A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
Issued on behalf of VentriPoint Diagnostics Ltd. 
From USA News Group
Via GlobeNewswire
News headline image
The Infrastructure Play Hiding in Plain Sight Across Cardiac Care
Issued on behalf of VentriPoint Diagnostics Ltd. 
From Equity Insider
Via GlobeNewswire
News headline image
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
Issued on behalf of VentriPoint Diagnostics Ltd. 
From USA News Group
Via GlobeNewswire
News headline image
THE SIGNAL ARCHITECTURE: 5 Stocks Calibrating the 2026 Infrastructure Cycle
Issued on behalf of Quantum Secure Encryption Corp. 
From USA News Group
Via GlobeNewswire
News headline image
THE SOVEREIGNTY DOCTRINE: 5 Assets Locking Down the 2026 Survival Cycle
Issued on behalf of Quantum Secure Encryption Corp. 
From USA News Group
Via GlobeNewswire
News headline image
AI Diagnostics: The End of the High-Cost Imaging Era
Issued on behalf of VentriPoint Diagnostics Ltd. 
From Equity Insider
Via GlobeNewswire
News headline image
THE SCARCITY DOCTRINE: 5 Assets Securing the 2026 Material Cycle
Issued on behalf of Ventripoint Diagnostics Ltd. 
From Equity Insider
Via GlobeNewswire
News headline image
THE FOUNDATION TRADE: 5 Assets Anchoring the Next Industrial Cycle
Issued on behalf of GoldHaven Resources Corp. 
From USA News Group
Via GlobeNewswire
News headline image
THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis
Issued on behalf of Ventripoint Diagnostics Ltd. 
From USA News Group
Via GlobeNewswire
News headline image
Healthcare AI Exits Pilot Phase, Enters Production Deployment
Issued on behalf of VentriPoint Diagnostics Ltd. 
From Equity Insider
Via GlobeNewswire
News headline image
From Hype to P&L: Hospitals Now Buying AI That Pays
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. 
From USA News Group
Via GlobeNewswire
News headline image
THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality
Issued on behalf of Oncolytics Biotech Inc. 
From USA News Group
Via GlobeNewswire
News headline image
UPDATE -- The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality
Issued on behalf of Oncolytics Biotech Inc. 
From USA News Group
Via GlobeNewswire
News headline image
The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality
Issued on behalf of Oncolytics Biotech Inc. 
From USA News Group
Via GlobeNewswire
Ventripoint's Next Generation, AI-powered Heart-Scanning Technology Submitted for EU Medical Device Regulation Certification
Toronto, Ontario - TheNewswire - (October 11, 2024) - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTCQB:VPTDF) is pleased to announce that it has submitted its next... 
Via TheNewswire.com
Topics Artificial Intelligence
Ventripoint Welcomes Evelina London Children's Hospital as Newest VMS+ User
Toronto, Ontario – TheNewswire – August 22, 2023 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) is pleased to announce that Evelina London Children’s Hospital... 
Via TheNewswire.com
Ventripoint to Exhibit at the American College of Cardiology 71st Annual Scientific Session and Expo and Correction to North Equities Corp Grant of Stock Options
Toronto, Ontario – TheNewswire – April 1, 2022 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce that it will be exhibiting at the 71st... 
Via TheNewswire.com
Ventripoint Announces Patent Application for Improved Heart Analysis
Toronto, Ontario – TheNewswire – August 09, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) has filed an international patent application under the Patent... 
Via TheNewswire.com
Topics Artificial Intelligence Intellectual Property
Ventripoint Engages Digital257 for Social Media and Investor Relations Services
Toronto, Ontario – TheNewswire – July 5, 2021 - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company "), (TSXV:VPT ) ; (OTC:VPTDF) is pleased to announce that it has engaged Digital257... 
Via TheNewswire.com
Topics Artificial Intelligence
Ventripoint Issues Option Grants to Consultants and a Director of the Corporation
Toronto, Ontario – TheNewswire – July 2, 2021 - Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”) (TSXV:VPT) (OTC:VPTDF) announces that on July 1, 2021 the Board of Directors... 
Via TheNewswire.com
Topics Artificial Intelligence
Ventripoint Announces Sponsorship for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology
Ventripoint Also Provides a Financial Update 
Via TheNewswire.com
Topics Artificial Intelligence
Ventripoint update on its Financial Status and on Warrant and Option Exercises
Toronto, Ontario – TheNewswire – May 6, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to provide this update on its financial status and the... 
Via TheNewswire.com
Topics Artificial Intelligence
Ventripoint Receives Government Funding to Advance Development of Next Generation of VMS+
Toronto, Ontario – TheNewswire – May 4, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is excited to announce that it is receiving advisory services and... 
Via TheNewswire.com
Topics Artificial Intelligence
Ventripoint Collaborates with GE Healthcare to Bring More Functionality to its Cardiac Ultrasound Devices
Toronto, Ontario - The Newswire - April 27, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) announces the Company has entered into a collaboration with GE... 
Via TheNewswire.com
Topics Artificial Intelligence
Ventripoint Attends 23rd Annual Canadian Echo Weekend and Grants Stock Options
Toronto, Ontario – TheNewswire – April 20, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) attended the 23rd Annual Canadian Echo Weekend – 2021 Digital... 
Via TheNewswire.com
Topics Artificial Intelligence
Ventripoint Extends Patent Portfolio with Foundational U.S. Provisional Patent Filing of Heart Motion Tracking Technology
Toronto, Ontario - The Newswire - April 19, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) has filed a U.S. provisional patent application for its novel... 
Via TheNewswire.com
Topics Artificial Intelligence Intellectual Property
Ventripoint Announces Sponsorship for the 2021 Canadian Society of Echocardiography Weekend Conference
Toronto, Ontario – TheNewswire – April 15, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce its sponsorship of the 2021 Canadian... 
Via TheNewswire.com
Topics Artificial Intelligence
Ventripoint Diagnostics Begins Publication of Case Studies Showing Meritorious Use of the VMS Heart Analysis System
Toronto, Ontario – TheNewswire – April 13, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) has published its first case study of the meritorious use of the... 
Via TheNewswire.com
Topics Artificial Intelligence
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.